Could it be worth MSB to partner aGVHD at this late stage?
If $700m in peak sales is to be believed and the high probability of FDA approval.
I'd be happy to see a partnership deal that offered $200m upfront and say a 50/50 split.
Surely the assistance of a big player would benifit global approvals and dealings with insurance companies all while providing an answer to our funding issues.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.30 |
Change
0.510(28.5%) |
Mkt cap ! $2.995B | |||
| Open | High | Low | Value | Volume |
| $1.90 | $2.40 | $1.90 | $29.24M | 13.40M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 10650 | $2.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.31 | 43627 | 14 |
View Market Depth
| Last trade - 11.57am 18/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |